AZN Today - Aug 08: Merger Talk Fades
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what happened? The stock kinda just floated along, not doing much. It’s almost like it was waiting for something to happen. Volume was normal, so no big panic or excitement. Just a steady day in the life of AZN.
Now, why the lack of fireworks? Well, the buzz around potential mergers seemed to fade a bit. Some folks were hoping for big news, but that chatter kinda fizzled out. Meanwhile, there’s been a lot of talk about AstraZeneca being undervalued, which has some people scratching their heads. It’s like, “What’s the deal?” On top of that, they just signed a new licensing deal with Sino Biopharm, and they’re teaming up for a new biologics manufacturing facility in China. That’s pretty cool and could mean some interesting developments down the line.
Oh, and here’s a little nugget: a firm just raised AstraZeneca’s 12-month price target, suggesting there could be some decent upside in the future. But again, just a target, so who knows?
All in all, it was a quiet day for AZN, but they’ve got some interesting stuff happening behind the scenes. Remember, this is all just info for you to think about, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません